Kairat Tabynov
8 Abay Avenue
Almaty, ALA 050010, Kazakhstan
Almaty, ALA 050010, Kazakhstan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Ultra-short recombinant Art v 1 immunotherapy induces rapid immune modulation in mugwort allergy: A Phase I trial.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: April 03, 2026
Adjuvant Strategies to Improve the Efficacy of Allergen Immunotherapy.
Journal: Journal of inflammation research
Published: October 14, 2025
Intranasal monoclonal antibodies to mugwort pollen reduce allergic inflammation in a mouse model of allergic rhinitis and asthma.
Journal: Frontiers in immunology
Published: March 18, 2025
The role of major allergens Art v 1 and Art v 3 in Artemisia pollen-induced asthma: a mouse model study.
Journal: Frontiers in immunology
Published: March 10, 2025
Evaluation of commercial vaccines for efficacy and transmission control against the emergent H5N8 (clade 2.3.4.4b) avian influenza virus in Kazakhstan.
Journal: Virology
Published: March 04, 2025
Evaluation of safety, immunogenicity, and efficacy of inactivated reverse-genetics-based H5N8 highly pathogenic avian influenza virus vaccine with various adjuvants via parenteral and mucosal routes in chickens.
Journal: Frontiers in immunology
Published: December 04, 2024
Historical Assessment and Mapping of Human Plague, Kazakhstan, 1926-2003.
Journal: Emerging infectious diseases
Published: November 26, 2024
Comparison of rArt v 1-based sublingual and subcutaneous immunotherapy in a murine model of asthma.
Journal: NPJ vaccines
Published: October 08, 2024
Detection and genomic characterization of an avian influenza virus A/mute swan/Mangystau/1-S24R-2/2024 (H5N1; clade 2.3.4.4b) strain isolated from the lung of a dead swan in Kazakhstan.
Journal: Microbiology resource announcements
Published: July 22, 2024
Evaluation of a SARS-CoV-2 spike protein ectodomain subunit vaccine with a squalene emulsion adjuvant in rodents and rhesus macaques.
Journal: Human vaccines & immunotherapeutics
Published: October 26, 2023
Author Correction: An intranasal vaccine comprising SARS‑CoV‑2 spike receptor‑binding domain protein entrapped in mannose‑conjugated chitosan nanoparticle provides protection in hamsters.
Journal: Scientific reports
Published: August 01, 2023
Last Updated: 09/26/2026